A pseudogene has been identified for ID2, a protein that may play a role in negatively regulating cell differentiation; a recent study from researchers at Columbia University states that ID2 protein has a relevant role in the development and resistance to therapies of glioblastoma.
A pseudogene has been identified for this gene. DNA-binding protein inhibitor ID-2 is a protein that in humans is encoded by the ID2 gene. This protein may play a role in negatively regulating cell differentiation. A research published by "Nature" in 01/2016, authored by Italian researchers Antonio Iavarone and Anna Lasorella, from Columbia University, states that ID2 protein has a relevant role in the development and resistance to therapies of glioblastoma, the most aggressive of brain cancers. 
